Langley RG, Sofen H, Dei-Cas I, Reich K, et al. Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials. Br J Dermatol 2023;188:198-207.
PMID: 36763857